Cytoplasmic expression of estrogen receptor beta (ERβ) predicts poor clinical outcome in advanced serous ovarian cancer

Cancer Statistics, 2010

Ahmedin Jemal, Rebecca L. Siegel, Jiaquan Xu et al. · CA A Cancer Journal for Clinicians · 2010 · 12.6K citations · Full text

Estimates of the cancer incidence and mortality in Europe in 2006

Jacques Ferlay, Philippe Autier, Mathieu Boniol et al. · Annals of Oncology · 2007 · 4K citations · Full text

Epidemiology, Cancer Epidemiology, Medicine +8

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

Andreas du Bois, Eric Pujade‐Lauraine, Philipp Harter et al. · Cancer · 2009 · 1.6K citations · Full text

Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis

R.E. Bristow · Journal of Clinical Oncology · 2002 · 877 citations

Surgical Oncology, Cancer Management, Gynecology +17

Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients.

Simona Mozzetti, Cristiano Ferlini, Paola Concolino et al. · PubMed · 2005 · 327 citations

Endocrine-related Cancer, Medicine, Paclitaxel Resistance +15